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1. Introduction 
Major sarcomeric thick filaments' protein of mammalian skeletal muscles is myosin. The 
thick myosin filament is composed of hexameric myosin molecules consisting of 2 myosin 
heavy chain (MyHC) subunits and 4 myosin light chain subunits (2 pairs of nonidentical 
light chains). The globular, amino terminal head domain, of MyHC has binding sites for 
actin and ATP. The elongated, alpha-helical coiled-coil carboxyl-terminal rod domain of 
MyHC exhibits filament forming properties, for review see (1). Several distinct MyHC 
isoforms exist. Human limb and trunk muscles contain muscle fibres expressing skeletal 
muscle-specific MyHC isoform IIA (MyHC-IIA) encoded by MYH2 gene on chromosome 17, 
MyHC isoform IID/IIX (MyHC-IIX) (2-4) encoded by MYH1 gene on chromosome 17 and an 
isoform that is expressed in both skeletal and cardiac muscle MyHC-β or MyHC-I encoded 
by MYH7 gene on chromosome 14 (5, 6). Two developmental myosin heavy chain isoforms 
(MyHC- embryonic and MyHC- perinatal) may be present in adult muscles, particularly in 
regenerating muscle fibres. MyHC family in humans includes also cardiac specific isoform 
MyHC-α and specialized isoform expressed in extraocular muscles (MyHC-extraocular) (6, 
7). The forth skeletal muscle-specific isoform MyHC-IIB, is expressed in mice and rat 
skeletal muscles and is thought not to be expressed in adult human muscles at the protein 
level; however MyHC-IIB mRNA has been detected in specialized human muscles (8, 9) and 
in limb muscles of patients suffering from Duchenne muscular dystrophy (10), suggesting 
that MyHC-IIB gene in humans can be reactivated in skeletal muscles undergoing profound 
degeneration/regeneration. 
In humans MyHC isoforms could be expressed either as single isoforms (in pure fibres-I, IIA 
and IIX) or co-expressed in different proportions in hybrid fibres (mainly -I/IIA, -IIA/IIX and 
-I/IIA/IIX). Hybrid fibres could reflect either a state of transition toward an isoform that is 
stimulus dependent or a state of stability (11). In normal conditions the proportion of hybrid 
 
Skeletal Muscle – From Myogenesis to Clinical Relations 360 
fibres depends on age, gender and physical activity: The studies of Williamson et al. (11, 12) 
showed that in young untrained women the proportion of hybrid fibres was 30%, in young 
untrained man the proportion was 40% (12) and in older untrained man the proportion was 
about 30% (11). In young and old the proportion of hybrid fibres decreased with progressive 
resistance training (11, 12) (though differences exist with respect to the type of MyHC 
upregulation).  
Muscle fibre typing which includes subclassification of fast fibres (distinction between IIA 
and IIX fibres) and identification of hybrid fibres by the type of MyHC isoform or by the 
activity of myofibrillar ATP-ase is technically quite a demanding process, since it requires 
serial muscle sections, is time consuming and expensive. Besides, identification of hybrid 
fast fibres by ATP-ase activity is generally not accurate (11).  
Identification of muscle fibre types on a single muscle section applying specific antibodies to 
MyHC isoforms could enhance and simplify the phenotyping (13, 14). Gregorevic et al. (13) 
presented on animal muscles sequential staining of a single section with three different MyHC 
specific antibodies (MyHC-I, MyHC-IIA, MyHC-IIB) labelled with different fluorophores. 
Raheem et al. (14) applied on human muscles sequential immunohistochemical staining of a 
muscle section with antibodies against two MyHC isoforms (MyHC-I and MyHC-IIA), where 
first antigen was visualized with peroxidase and the second with alkaline phosphatase-
conjugated secondary antibodies. Neither Gregorevic et al. (13) nor Raheem et al. (14) 
identified IIX fibres with antibodies specific to MyHC-IIX, but only by exclusion, i.e. fibres not 
immunoreactive with antibodies to MyHC-I, MyHC-IIA and MyHC-IIB in animals or MyHC-I 
and MyHC-IIA in humans were identified as IIX fibres.  
In this study we compare methods for muscle fibre phenotyping on a single section with 
those on serial sections and discuss the advantages and limits of muscle phenotyping on a 
single section. In addition we demonstrate that A4.74 antibody, otherwise declared to be 
specific for MyHC-IIA in humans (14, 15), cross-immunoreacts with IIX fibres in humans, 
consistent with Smerdu and Soukup (16).  
2. Methods  
Muscle fibre phenotyping was performed according to the expression of myosin heavy 
chain isoforms (MyHC) by indirect immunoperoxidase method using anti-mouse 
immunoglobulins as secondary antibodies (P260, DAKO) as described previously (4, 16), 
except for IIX fibres where Novolink polymer detection system (Novocastra secondary 
antibodies, Leica Microsystems) was used as recommended by the manufacturer. Briefly 
slow fibres were demonstrated by BA-D5 antibody immunoreactive with /slow MyHC-I in 
rats (2) and humans (5) in a dilution 1:100;  fast fibres were demonstrated by A4.74 antibody 
(former Alexis Biochemicals, now Enzo Life Sciences) immunoreactive according to the 
product data sheet in rats and humans  with MyHC-IIA, but according to (16) with MyHC-
IIA and MyHC-IIX in humans and in dogs (17). A dilution of A4.74 was 1:100. 
Immunoreaction using A4.74 antibody was developed either with peroxidase-conjugated 
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anti-mouse immunoglobulins (P260, DAKO) or with alkaline phosphatase-conjugated anti-
mouse immunoglobulins (D486, DAKO). IIX fibres were demonstrated by 6H1 antibody 
developed by Lucas (18) in a dilution 1:3000. BF-35 antibody which stains all muscle fibres, 
except fibres expressing MyHC-IIX (2) was used undiluted. Muscle fibre phenotyping on 
serial muscle sections was compared with two double immunoenzyme staining methods (i) 
described by Raheem et al. (14) and (ii) our own modification. Briefly, in (i) a single muscle 
section was successively treated with antibodies against MyHC-I (BAD5) and antibodies 
declared as specific against MyHC–IIA (A4.74). First primary antibody was visualized with 
peroxidase and the second with alkaline phosphatase. BCIP/NBT (Sigma) was used as a 
substrate for alkaline phosphatase. In the second modification (ii) we successively applied 
antibodies against MyHC-IIX (6H1) and antibodies declared as specific against MyHC–IIA 
(A4.74). Autopsy samples of vastus lateralis muscle of two healthy males who died 
suddenly were obtained within 12 hours after death. Muscle sampling was approved by the 
National Medical Ethical Committee of the Republic of Slovenia.  
3. Results  
Consistent with (16) we demonstrated that antibody A4.74 reacts in human vastus lateralis 
muscle with both MyHC-IIA and MyHC-IIX fibres (Fig. 1 and Fig. 2). 
Higher dilutions of A4.74 antibodies did not eliminate staining of IIX fibres at dilutions at 
which IIA fibres could be stained reasonably well (results not shown). 
Comparison of fibre phenotyping with the method of Raheem et al. (14) and fibre 
phenotyping on serial sections is presented in Fig. 3. 
Double immunoenzyme staining method (Fig. 3a) demonstrates well muscle fibres 
expressing MyHC-I (slow fibres), all fast fibres (IIA and IIX fibres) as one group, as well as 
hybrid fibres IIA/I in which MyHC-IIA predominates (IIA>I). However the relative 
proportion of individual MyHC isoforms can not be estimated from a single section. Hybrid 
fibres IIA/I with similar contributions of MyHC-IIA and MyHC-I (IIAI) (upper fibre with 
white asterisk in Fig. 3) and hybrid fibres with higher proportion of MyHC-I as MyHC-IIA 
(IIIA) (lower fibre with white asterisk in Fig. 3) can not be recognised on a single section 
but only on serial sections. Hybrid IIA/IIX fibres, expressing MyHC-IIA and MyHC-IIX 
(fibres labelled with black dots () in Fig. 3) can be identified on serial sections only, because 
with the double staining method (and with A4.74 antibodies – Fig. 3b) they can not be 
distinguished from IIA fibres.  
Distinguishing between slow and fast fibres can be successfully accomplished already with 
a single type of antibodies as BAD5 antibodies (stain all slow fibres) or A4.74 antibodies 
(stain all fast fibres) in humans. Unstained fibres in either case belong to other main group 
of muscle fibres (fast – Fig. 3c or slow – Fig. 3b). 
Subtyping of fast fibres is more difficult. Antibodies to both, MyHC-IIA and MyHC-IIX have 
to be used. To see, whether it is possible to determine hybrid IIX/IIA fibres on a single 
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section, we successively applied antibodies against MyHC-IIX (6H1) and antibodies against 
MyHC-IIA + MyHC-IIX (A4.74) and compared the results with subtyping of fast fibres on 
serial sections and with double immunoenzyme staining method of Raheem et al. (14) (Fig. 4). 
 
 
 
 
Figure 1. Immunoreactivity of A4.74 antibodies compared to immunoreactivity of 6H1 and BAD-5 
antibodies on serial sections of human vastus lateralis muscle.  
(a): A4.74 antibodies were declared as specific for MyHC-IIA, however A4.74 antibodies render an 
intense immunoreactivity in IIA fibres, in hybrid IIA/IIX fibres and a moderate immunoreactivity in IIX 
fibres. They do not stain slow fibres. (b): 6H1 antibodies specific for MyHC-IIX have relatively intense 
immunoreactivity in IIX fibres and hybrid IIA/IIX fibres. They do not stain IIA fibres and slow fibres. 
(c): BAD-5 antibodies specific for MyHC-I have intense immunoreactivity in I fibres. They do not stain 
IIA, IIX and hybrid IIA/IIX fibres. 
Fibres labelled with dots (): hybrid fibres IIA/IIX which express MyHC-IIA (a) and MyHC-IIX (b) and 
do not express MyHC-I (c). Fibres labelled with asterisks (*): hybrid fibres IIA/I which express MyHC-
IIA (a) and MyHC-I (c) and do not express MyHC-IIX (b). IIA fibres: intense immunoreactivity with 
A4.74 antibodies, negative with 6H1 antibodies and BAD-5 antibodies. IIX fibres: relatively intense 
immunoreactivity with 6H1 antibodies (b), moderate immunoreactivity with A4.74 antibodies (a) and 
negative with BAD-5 antibodies (c). Slow or I fibres: intense immunoreactivity with BAD-5 antibodies 
(c), negative with A4.74 and 6H1 antibodies. 
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Figure 2. Immunoreactivity of A4.74 antibodies compared to immunoreactivity of 6H1 and BF-35 
antibodies on serial sections of human vastus lateralis muscle.  
(a): A4.74 antibodies show an intense immunoreactivity in IIA fibres and hybrid IIA/IIX fibres and also 
a moderate immunoreactivity in IIX fibres. (b): 6H1 antibodies have intense immunoreactivity in IIX fibres 
and hybrid IIA/IIX fibres. (c): BF-35 antibodies stain all muscle fibres except “pure” IIX fibres which do 
not co-express other MyHC isoforms. Fibres labelled with dots (): hybrid IIA/IIX fibres which express 
MyHC-IIA (a) and MyHC-IIX (b) and are all immunoreactive with BF-35 antibody (c). IIX fibres: intense 
immunoreactivity with 6H1 antibodies (b), moderate immunoreactivity with A4.74 antibodies (a) and 
negative with BF-35 antibodies (c).  
Due to cross-immunoreactivity of A4.74 antibodies with pure IIX fibres separation of IIX 
and other fast fibres (IIA fibres and IIA/IIX fibres as a group) is possible already with A4.74 
antibodies where unstained fibres are slow fibres (Fig. 1a, Fig. 2a, Fig. 3b, Fig. 4b). A4.74 
antibodies alone can not distinguish between “pure” IIA fibres and hybrid IIA/IIX fibres. 
With double immunostaining of IIA and IIX fibres (Fig. 4c) no additional information is 
provided. Hybrid fibres IIA/I can not be visualised with this method (fibres labelled with 
arrows and white asterisks in Fig. 4). 
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Figure 3. Phenotyping of muscle fibres with the double immunoenzyme staining method according to 
Raheem et al. (14) on a single section compared to phenotyping of muscle fibres on serial sections.  
(a): Double immunoenzyme staining – applying antibodies against MyHC-I (BAD5) and antibodies 
against MyHC-IIA + MyHC-IIX (A4.74). (b-d): Immunohistochemical reactions with individual 
antibodies. (b): against MyHC-IIA + MyHC-IIX (A4.74) visualized with alkaline phosphatase. (c): 
against MyHC-I (BAD-5) visualized with horseradish peroxidase. (d): against MyHC-IIX (6H1) 
visualized with horseradish peroxidase. Fibres labelled with black asterisks (*) are IIX fibres. Fibers 
labelled with black dots () are hybrid IIA/IIX fibres. Fibres labelled with arrows are hybrid IIA/I (IIAI) 
fibres. Fibres labelled with white asterisks (*) are hybrid IIA/I (IIAI) or (IIIA) fibres (upper and lower 
fibre). 
Neither double staining method identifies hybrid fibres co-expressing MyHC-IIA and 
MyHC-IIX (IIA/IIX). Hybrid fibres IIA/IIX can not be separated either form IIA fibres (in 
double immunostaining with BAD-5 and A4.74 antibody) ((Fig. 3a, Fig. 4a)) or from IIX 
fibres (in double immunostaining with 6H1 and A4.74 antibody) (Fig. 4c). 
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Figure 4. Double immunoenzyme staining according to Raheem et. al. (14) and double immunoenzyme 
staining of fast (IIA and IIX) fibres compared to phenotyping of muscle fibres on serial sections.  
(a): Double immunoenzyme staining method according to Raheem et al. (14) successively applying 
antibodies against MyHC-I (BAD5) and antibodies against MyHC-IIA+ MyHC-IIX (A4.74). (c): Double 
immunoenzyme staining of fast fibres successively applying antibodies against MyHC IIX (6H1) and 
antibodies against MyHC-IIA+ MyHC-IIX (A4.74). (b) and (d) are immunohistochemical reactions with 
individual antibodies. (b): against MyHC-IIA+ MyHC-IIX (A4.74) visualized with alkaline phosphatase. 
(d): against MyHC-IIX (6H1) visualized with horseradish peroxidase. Fibres labelled with black asterisks 
(*) are IIX fibres. Fibres labelled with black dots () are hybrid IIA/IIX fibres. Fibres labelled with arrows 
are hybrid IIA/I (IIAI) fibres. Fibres labelled with white asterisks (*) are hybrid IIA/I (IIAI) or (IIIA) 
fibres (upper and lower fibre). 
4. Discussion 
Similarly to Smerdu and Soukup (16) we have demonstrated in human vastus lateralis 
muscle that A4.74 antibodies which should be specific for muscle fibres expressing MyHC-
IIA weakly stain also MyHC-IIX expressing fibres. The latter were not hybrid IIX/IIA fibres, 
but pure IIX fibres, since the corresponding fibres were negative with BF-35 antibodies, 
which stain all muscle fibres, except fibres expressing MyHC-IIX (2, 19). Smerdu and 
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Soukup (16) showed that muscle fibres stained weakly with A4.74 antibodies and strongly 
with antibodies specific for MyHC-IIX (6H1) in humans  expressed exclusively MyHC-IIX 
mRNA, which further confirms that weakly stained fibres are pure IIX fibres. Recently, 
Bloemberg and Quadrilatero (20) showed that SC-71 antibody, another antibody directed 
against MyHC-IIA, also cross-reacts with IIX fibres, as already also described by Smerdu 
and Soukup (16). A4.74 antibodies thus stain dark fibres expressing MyHC-IIA (fibres IIA 
and hybrid fibres IIA/IIX) and stain intermediate fibres expressing MyHC-IIX (Fig.1a, Fig. 
2a, Fig. 3b, and Fig. 4b).  
Both techniques for phenotyping of muscle fibres on a single section, triple 
immunofluorescent method (13) and double immunoenzyme staining method (14) did not 
directly identify IIX fibres (by antibodies to the MyHC-IIX). We have demonstrated that 
hybrid fibres IIX/IIA are missed by double immunoenzyme staining method (14) as they are 
misclassified as IIA fibres (Fig. 3a). Similar would hold also for the triple 
immunofluorescence method mentioned above, as antibodies to the MyHC-IIX were not 
used. The colour of the reaction product in hybrid IIX/IIA fibres, which are not recognised 
as such, does not change (remains blue) during superposition on immune reaction with 
antibodies directed against MyHC-I, since MyHC-I are not expressed in these hybrid fibres. 
We have clearly demonstrated (Fig. 3) that the staining intensity of MyHC-IIA in hybrid 
fibres can be as intensive as in pure IIA fibres, but to prove that such a fibre is a hybrid fibre, 
serial sections including immunohistochemical reaction to MyHC-IIX must be analysed.  
The hybrid fibres IIA/I can be demonstrated with this method, if the proportion of MyHC-
IIA predominates (IIAI) in hybrid fibres (fibres labelled with arrows in Fig. 3), but if 
proportions are similar (IIAI) or MyHC-1 predominates (IIIA), such fibres are missed 
(fibres labelled with white asterisks in Fig. 3).  
We conclude that hybrid fibres can be reliably demonstrated only on serial muscle sections. 
They may be demonstrated on a single section, if staining with antibodies directed to both 
MyHC expressed in hybrid fibres are used, but this may not be valid for all proportions of 
individual MyHC in hybrid fibres. By no means can hybrid fibres co-expressing three types 
of different MyHC be demonstrated by the double staining method. Nevertheless, the 
method of Raheem et al. (14) was not developed for demonstration of hybrid fibres, but as 
an alternative to routine ATP-ase staining in diagnostics of myopathies and can be 
particularly useful for demonstrating of advanced atrophic fibres in conditions as myotonic 
dystrophy type 2 (14) which justifies it as a good method for routine diagnostics.  
The double immunoenzyme staining method (14) in addition presents well slow fibres 
expressing MyHC-I and all fast fibres, expressing either MyHC-IIA or MyHC-IIX, but IIA 
and hybrid IIA/IIX fibres can not be distinguished. The distinction between fast and slow 
fibres can be accomplished already by staining of muscle section with antibodies to MyHC-I 
alone. Double immunoenzyme staining offers more clear presentation of fast fibres' 
contours, which may be as “unstained” fibres difficult to present in sections stained only 
with antibodies to MyHC-I (Fig. 3c), especially in clusters of fast fibres. Alternatively, 
antibodies to MyHC-IIA, as A4.74 and SC-71, which also cross-react with MyHC-IIX (16, 20) 
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can also be used to separate fast and slow fibres on a single section. In this case slow fibres 
are unstained (Fig. 3b or Fig. 4b). Obviously the advantage of the double immunoenzyme 
staining of Raheem et al. (14) is in (i) the clear simultaneous presentation of fast and slow 
fibres and (ii) presentation of “pure” IIX fibres (not co-expressing other MyHC isoforms); 
the latter is possible due to cross-reactivity of antibodies to fast fibres (A4.74 and SC-71) as 
mentioned above, but identification of hybrid fibres is unsatisfactory and therefore also the 
separation of IIA fibres and hybrid fibres co-expressing MyHC-IIA and MyHC-IIX.  
In our own modification of double immunoenzyme staining method in which we 
superimposed two immunohistochemical reactions for demonstration of fast fibres (IIA and 
IIX), we demonstrated that IIX fibres can not be reliably distinguished from hybrid fibres 
IIX/IIA, since the differences in colours were negligible (Fig. 4c). We consider this as an 
additional proof that demonstration of hybrid fibres on a single section is tricky, even if two 
corresponding antibodies to MyHC isoforms expected to be co-expressed in hybrid fibres 
are used. The mixed colour of the two reaction products may simply reflect the dominance 
of one colour and may not be correlated to the proportions of MyHC isoforms. In Fig. 4c in 
hybrid IIX/IIA fibres the brownish colour of MyHC-IIX isoforms completely covered the 
blue colour of the MyHC-IIA isoforms. Similar is valid also for the demonstration of hybrid 
fibres I/IIA (I~IIA and I>IIA), labelled with white asterisks in Fig. 3, in which strong brown 
colour of the reaction product of MyHC-I also completely covered the blue colour of MyHC-
IIA. In addition, with double immunoenzyme staining technique it is assumed, that first 
primary antibody (in our case BAD-5) is completely coupled with the secondary antibodies 
(in our case peroxidase-conjugated secondary antibodies). However, the cross-
immunoreactivity of secondary phosphatase-conjugated antibodies with the primary 
antibodies (BAD-5) can not be excluded. As expected we could not identify hybrid IIA/I 
fibres by superimposing two immunohistochemical reactions to fast fibres, as antibodies to 
MyHC-I were not used.  
Recently Bloemberg and Quadrilatero (20) reported on rapid determination of myosin heavy 
chain expression on a single section using multicolour immunofluorescent method on 
animal and human muscle. In human muscle they used three different primary antibodies 
against different MyHC isoforms, including antibody to MyHC-IIX (18). The method takes 
the advantage of the fact that antibodies against MyHC isoforms, belong to different 
subtypes of immunoglobulins: IgG2b (against MyHC-I), IgG1 (against MyHC-IIA) and IgM 
(against MyHC-IIX). Muscle fibres immunoreactive with particular antibody can be 
visualised with secondary antibodies specific for only one subclass of immunoglobulins and 
labelled with different fluorophores. The authors were able to demonstrate major fibre types 
and hybrid I/IIA and IIX/IIA fibres. However, the identification of hybrid IIX/IIA fibres on 
merged images is not straightforward, but hybrid fibres can be recognised, if analysing all 
single channel images (see their Fig. 5). Also the reported percentage of hybrid fibres in this 
study (20) is much lower than in the previous studies using single fibre electrophoresis (11, 
12). It seems that the advantage of multicolour fluorescent method is the possibility to 
analyse single channel images, that is similar to analysis of individual serial sections, to 
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identify especially hybrid fibres with two MyHC isoforms (20) and possible also with three 
MyHC isoforms, if in doubts on merged images.  
If different fluorophores are directly coupled to primary antibodies more than three labelled 
antibodies can be used on the same section (13) and antibodies as MyHC-neonatal and 
MyHC-embryonic, which are expressed during development and regeneration, can be 
demonstrated on the same section with other myosin antibodies. In addition when using 
multicolour immunofluorescent method correlation between metabolic profile of muscle 
fibres and contractile characteristics can be studied more easily (20). Obviously metabolic 
profile can be identified in next two consecutive muscle sections where tracing of muscle 
fibres is easier than in more distant muscle sections. Adjustments of orientations of muscle 
profiles in distant sections are sometimes necessary with specialised computer programs for 
image analysis as (21). Theoretically total of six emission/detection channels can be used 
(13), if primary antibodies are directly coupled with fluorophores which have very narrow 
emission spectrum. Besides different antibodies to MyHC isoforms antibodies to other 
proteins labelled with distinct fluorophores may be included and the results correlated to 
contractile profiles of muscle fibres. However, when analysis is based on mixed colours full 
attention must be paid to possible misinterpretation of staining artefacts as hybrid fibres.  
5. Conclusion 
A good agreement was found between muscle fibre phenotyping on serial muscle sections 
and muscle fibre phenotyping on a single section by double immunohistochemical staining 
method, if muscle fibres expressed a single MyHC isoform. The identification of hybrid 
fibres expressing two different MyHC isoforms requires the superposition of both 
antibodies directed against MyHC isoforms which are expressed in hybrid fibres. Even then, 
the identification of hybrid fibres may not be successful: it depends on relative proportions 
of individual MyHC isoforms. In addition cross reactivity of secondary antibodies with 
primary antibodies may hinder identification of hybrid fibres. Hybrid fibres expressing 
three different MyHC isoforms can not be presented with the double immunohistochemical 
staining method. 
Muscle fibre phenotyping on serial muscle sections was definitely superior to the double 
staining method performed on a single section, when hybrid fibres were present.  
The multicolour immunofluorescent method applying three different antibodies to major 
adult MyHC isoforms in human skeletal muscle (MyHC-I, MyHC-IIA, and MyHC-IIX) on a 
single muscle section may be a promising tool in simplifying muscle phenotyping and in 
identifying hybrid fibres. Primary antibodies to MyHC isoforms directly labelled with 
fluorophores enable simultaneous use of larger number of antibodies against MyHC as 
mentioned above. Presentations of MyHC isoforms and other proteins on the same section 
would also be an interesting application of the multicolour fluorescent method in further 
studies. Nevertheless, combination of more reactions on a single section means also 
combination of all artefacts that accompany individual procedures. Therefore all combined 
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reaction procedures must be applied with full precaution; otherwise they might turn into 
misinterpretations of artefacts. 
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